H. pylori, a carcinogen: the need for testing and eradicating is REAL
Labeled a carcinogen by the World Health Organization, H. pylori, if left untreated, is a major cause of ulcers
and strongly linked to stomach cancer. Yet, many patients remain unknowingly infected and often untested or
masked over with PPI prescriptions. Testing for H. pylori in symptomatic patients has become
the standard of care worldwide.
Are your patients at risk?
Are they getting the best possible care?
Scary truth: The Center for Disease Control in the US estimated that one in three of your patients is most likely infected with H. pylori, with some areas and populations in the US having an H. pylori prevalence greater than 60%
Clear Choice, Smart Choice: Urea Breath Testing (UBT)
When it comes to testing for H. pylori, Urea Breath Testing (UBT) is the recommended method of choice. UBT is quick, patient-friendly, noninvasive, and arguably the most accurate of non-endoscopic testing methods. However, too many patients undergo inaccurate serology testing, unable to definitively detect active infection or resolved infection.
“A positive blood antibody test is no better than a coin toss for predicting active H. Pylori infection”
BreathID® Hp Urea Breath Test
The shifting evolution in H.pylori diagnostic testing
Prolonged H. pylori infection,
including untreated early childhood exposure to infection,
“may predispose patients to chronic disease, as well as significantly increase the risk of gastric cancer.
The impact on health as an adult highlights the need for eradication.”
Guarner J, Bartlett J, Whistler T, et al. “Can pre-neoplastic lesions be detected in gastric biopsies of children
with Helicobacter pylori infection?” J Pediatr Gastroenterol Nutr. 2003;37(3):309-314.
Point-of-Care or Automated batch testing for labs
In both cases, you can test your patients in the convenience of your practice, and either provide immediate
results with your in-office BreathID® Hp, or collect breath samples to send to the lab for automated analysis.